Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Giulia Orlando, who has become a 2021 Leukaemia UK John Goldman Fellow.

A smiling woman in a grey top. Next to her image is written '2021 Leukaemia UK John Goldman Fellows Announced'.

This week Dr Giulia Orlando, a postdoctoral researcher in the Haematopoietic Stem Cell Biology Group has been announced as one of five new Leukaemia UK John Goldman Fellows for 2021.

The Fellowships, created in honour of Professor John Goldman, aim to support early career researchers to pursue novel research to treat blood cancer. To be successful applicants must demonstrate their potential as leaders of the future, pursuing research with the potential to impact the understanding and treatment of blood cancer.

Dr Orlando said: “During my John Goldman Fellowship I will study a rare form of childhood cancer, juvenile myelomonocytic leukaemia (JMML), characterised by alterations in RAS genes within cells. No target treatment is currently available for this type of leukaemia, and the only curative option is bone marrow transplant. Even after transplant, 35% of patients relapse. By studying the molecular mechanisms behind RAS driven gene regulation, I hope that this research might lead to new targeted treatments being employed to improve patient outcome.” 

For a full list of awardees, please visit the Leukaemia UK website

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Study links the onset of circulation to changes in metabolism affecting blood stem cell development

A new paper published in Cell Reports by the de Bruijn Group indicates that the onset of circulation triggers a metabolic switch associated with the maturation of haematopoietic stem cells.

Interview with Excellence Award winner Dr Susan Shapiro

A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.

Mohsin Badat receives ASH-BSH Abstract Achievement Award

Dr Mohsin Badat, a Clinical Training Research Fellow from the Higgs and Davies Groups has been awarded the ASH-BSH Abstract Achievement Award by the American Society of Haematology and the British Society of Haematology.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.